Browse
Archive Cases
- By Attorney
- By Case Name
- By Judge
- By Jurisdiction
- By Law Firm
- By Parties
- By Practice Area
- By Witness
State of Alaska v. Eli Lilly & Co - Trial
Overview
Case Name:
State of Alaska v. Eli Lilly & Co - Trial
Case Number:
3AN-06-05630CI
Start Date:
March 5, 2008
End Date:
March 26, 2008
Description:
The state of Alaska is bringing action against Eli Lilly on the claims of violation of Alaskas Unfair Trade Practices and Consumer Protection Act, failure to warn, design defect, negligence, and fraud and negligent misrepresentation. Alaska is seeking to recover the funds its Medicaid program spent treating the side effects of Eli Lillys drug Zyprexa, claiming that Eli Lilly failed to properly report the fact that use of the drug can lead to hyperglycemia and diabetes to the FDA, instead reporting that it can cause weight gain. The state asserts that Eli Lilly also failed to inform doctors of the risk of these side effects and instructed its representatives to deny the link between Zyprexa and diabetes. In 2003, the FDA mandated that Zyprexa includes warnings about hyperglycemia and diabetes.
Parties
- Plaintiff - State of Alaska
- Defense - Eli Lilly & Co